Skip to main content

An opportunity we shouldn't refuse

The current pandemic provides an opportunity offer we shouldn't refuse. Global alignment in regulatory processes for medicines has been slow. We should put funding and resources into refining the processes now, for the coming years of COVID management and for the next pandemic, outbreak or global emergency. 

It is refreshing to see WHO and ICMRA step up to the plate. They need unified support and resource-intensive investment, however. 

The world should examine WHO/ICMRA joint priorities, invest in labor for ICMRA and industry liaisons, and request polished organization. 


Priorities around well-designed clinical trials, endpoint and safety data strategies, sharing data for multi-country approvals, incorporating ICMRA regulatory agility in policies and protocols, supporting rapid response for global emergencies, transparency of trial results, strengthening public trust in vaccines, supporting the mitigation and prevention of drug shortages, COVID therapeutic surveillance, addressing safety and efficacy of COVID vaccines and medicines together, and reducing false and fraudulent therapeutic messaging are all achievable. Designing the effort for sustainability and ongoing process improvement in regulatory medicine requires resources. 


* Technological support should be funded based on identified need

* Flexibility for national autonomy should be documented and tracked, for process improvement worldwide

* Criterion by country should be transparent

* Clinical trial consensus should be immediately requested, there has been tremendous work around clinical trial improvements already

* Liaisons with government regulatory, pharmaceutical companies, research institutions and global governance should be funded

* Professional public messaging and communication should be funded 

* Formal strategic planning should be requested, with annual measures and reporting


The world should respect a tremendous effort by recognizing the tremendous opportunity we have. 

Comments

Post a Comment

Popular posts from this blog

Refugees, migrants and forcibly displaced persons

Continued pandemic management requires improved operations for forcibly displaced persons, migrants and refugees. Better organization for this population will expedite prevention and treatment for people, assist host countries and help prepare for future outbreaks. Organization for refugees, migrants and forcibly displaced persons should include:  * International oversight      R ecommendations and monetary awards for countries managing these populations should be supported with global analyses and follow up   .    Cohesive action should be driven by formal global planning, with experts at the table.    Real time analysis of host country needs and resources for the refugee and forcibly displaced population. If we are aware of the basics, we can improve real time analytics.  * Accountability    World Health Organization situational reports shape questions of accountability to epidemiological and surveillance improvements. E...
Post a Comment
Read more

Beyond the Board

Sometimes it takes more than a board of directors to ensure an agency or government is safeguarding our interests. This is particularly true in regulation.  While a country's best interests may not align with international agenda, regulation on behalf of safety and protection is almost always universal. Workarounds to regulation, often allowed of out of self interest or cost, should be tied to international repercussions.  Regulation of food, markets, environmental epidemiology and other early prevention in novel strains make a difference.  Upcoming pandemics and outbreaks can be avoided, or at least better addressed, with better regulation. The international community should gather several policy points, measures and international comparisons. The international health community should observe, encourage and report on countries with and without these policies.  The end of the year COVID-19 WHO report is dynamic and impressive. It is missing policy development and in...
Post a Comment
Read more

Flow riding

Emergency Medical Team partnerships have been impressive and we should be grateful for international collegiality. The training and development for COVID response can be applied to future infection control during individual transport, outbreaks and other emergencies.    How can we show gratitude as a global group? We can be at the table to help EMT response flow. *Meet, survey and collect information on logistical needs for EMT sustainability in these countries.  *Ask if logistics liaisons for operations coordination would be of use.   *Determine funding needs, policy alignment abilities and credentialing alignment potentials, worldwide. Assertively confront the acronym and credentialing discrepancies. Be direct about the difference in EMT, Technician versus Team . Resolve, fund and manage to move forward together.  *Consider first response systems worldwide, including dispatch and policing networks. Consider separate jurisdiction wherever corruption may fr...
Post a Comment
Read more